QUIDELORTHO CORP Stock-Based Compensation
QUIDELORTHO CORP (QDEL) reported Stock-Based Compensation of $22.70 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for the quarter ending 2026-06-28 was $12.00M, a 6.25% decline year-over-year.
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for the quarter ending 2026-03-29 was $10.70M, a 7.76% decline year-over-year.
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for the quarter ending 2025-12-28 was $10.80M, a 12.50% increase year-over-year.
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for the quarter ending 2025-09-28 was $10.70M, a 13.01% decline year-over-year.
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for fiscal 2025 was $45.90M, a 9.03% increase from fiscal 2024.
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for fiscal 2024 was $42.10M, a 18.41% decline from fiscal 2023.
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for fiscal 2023 was $51.60M, a 6.61% increase from fiscal 2023.
- QUIDELORTHO CORP share-based payment arrangement, noncash expense for fiscal 2023 was $48.40M, a 90.55% increase from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-28 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $22.70M 10-Q · filed 2026-08-07 | $33.50M derived: sum of 3 quarters · filed 2026-08-07 | $44.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $10.70M 10-Q · filed 2026-05-06 | $21.50M derived: sum of 2 quarters · filed 2026-05-06 | $32.20M derived: sum of 3 quarters · filed 2026-05-06 | $45.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $21.50M derived: sum of 2 quarters · filed 2026-02-19 | $34.30M derived: sum of 3 quarters · filed 2026-08-07 | $45.90M 10-K · filed 2026-02-19 |
| 2025-09-28 | $10.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $23.50M derived: sum of 2 quarters · filed 2026-08-07 | $35.10M 10-Q · filed 2025-11-06 | $44.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $24.40M 10-Q · filed 2026-08-07 | $34.00M derived: sum of 3 quarters · filed 2026-08-07 | $46.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $11.60M 10-Q · filed 2026-05-06 | $21.20M derived: sum of 2 quarters · filed 2026-05-06 | $33.50M derived: sum of 3 quarters · filed 2026-05-06 | $44.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $21.90M derived: sum of 2 quarters · filed 2026-02-19 | $33.10M derived: sum of 3 quarters · filed 2026-02-19 | $42.10M 10-K · filed 2026-02-19 |
| 2024-09-29 | $12.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $23.50M derived: sum of 2 quarters · filed 2025-11-06 | $32.50M 10-Q · filed 2025-11-06 | $44.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $11.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $20.20M 10-Q · filed 2025-08-06 | $32.50M derived: sum of 3 quarters · filed 2026-02-19 | $46.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $9.00M 10-Q · filed 2025-05-08 | $21.30M derived: sum of 2 quarters · filed 2026-02-19 | $35.40M derived: sum of 3 quarters · filed 2026-02-19 | $49.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $26.40M derived: sum of 2 quarters · filed 2026-02-19 | $40.60M derived: sum of 3 quarters · filed 2026-02-19 | $51.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | $14.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $28.30M derived: sum of 2 quarters · filed 2024-11-08 | $39.30M 10-Q · filed 2024-11-08 | $51.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $14.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $25.20M 10-Q · filed 2024-08-01 | $37.00M derived: sum of 3 quarters · filed 2025-02-27 | $50.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $11.00M 10-Q · filed 2024-05-09 | $22.80M derived: sum of 2 quarters · filed 2025-02-27 | $36.10M derived: sum of 3 quarters · filed 2025-02-27 | $52.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $25.10M derived: sum of 2 quarters · filed 2025-02-27 | $41.00M derived: sum of 3 quarters · filed 2025-02-27 | $48.40M 10-K · filed 2025-02-27 |
| 2022-10-02 | $13.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $29.20M derived: sum of 2 quarters · filed 2023-11-02 | $36.60M 10-Q · filed 2023-11-02 | $43.30M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $15.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $23.30M 10-Q · filed 2023-08-09 | $30.00M derived: sum of 3 quarters · filed 2024-08-01 | $37.00M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $7.40M 10-Q · filed 2023-05-04 | $14.10M derived: sum of 2 quarters · filed 2024-08-01 | $21.10M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $6.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $13.70M derived: sum of 2 quarters · filed 2024-08-01 | $25.40M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $18.70M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $11.70M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $21.00M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |